CYSLTR1: Cysteinyl leukotriene receptor 1
Receptor for cysteinyl leukotrienes mediating bronchoconstriction of individuals with and without asthma.
- Drugs that act on it: 4
- Approved: 3
- In phases 1 to 3: 1
- Sponsors: 3
Who is on it, and how far along
Every drug ChEMBL records acting on CYSLTR1, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 4
Sponsors
Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.
- Ono Pharmaceutical125%
- Organon125%
- Strides Pharma Science125%
The landscape
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Cysteinyl leukotriene receptor 1 antagonist.| MontelukastBoxed warning | Approved | Organon | Small molecule | Antagonist | 27 |
| Zafirlukast | Approved | Strides Pharma Science | Small molecule | Antagonist | 1 |
| Pranlukast | Approved | Ono Pharmaceutical | Small molecule | Antagonist | 0 |
| CR-3465 free acid | Phase 1 | — | Small molecule | Antagonist | 0 |
Open trials
The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 9 in all, from ClinicalTrials.gov.Diseases most associated with it
Open Targets association score, 0 to 1; all associationsDrugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1798, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt Q9Y271, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets